CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable ...
Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, ...
QUEBEC, Feb. 19, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating ...
“This article illuminates the biology behind EDG-5506, demonstrating that modulation of fast skeletal muscle contraction protects against muscle injury, degeneration and fibrosis in models of DMD,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results